Biofil Chemicals & Pharmaceuticals Ltd — Quarterly Results & Earnings

₹25.79

-4.48%

Profit Growth YoY300.00%Latest quarter

Sales Growth YoY461.83%Latest quarter

Sales CAGR 5Y2.38%5 year compound

Profit CAGR 5Y-14.28%5 year compound

📋

Quarterly Performance

YoY Profit Growth+300.00%

🔥 Exceptional growth

YoY Sales Growth+461.83%

🔥 Exceptional growth

OPM 5Y Average

Operating profit margin

3.56%

EPS Growth 5Y

-14.28%

Interest Coverage

Higher = safer debt servicing

112.67

ROE

3.03%

ROCE

4.12%

💡

Growth Analysis

Biofil Chemicals & Pharmaceuticals Ltd reported YoY profit growth of 300.00% and revenue growth of 461.83% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at 2.38% and profits at -14.28% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Biofil Chemicals & Pharmaceuticals Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.